Scorpius Holdings, Inc., a pharmaceutical company based in North Carolina, with a current market capitalization of $1.14 million and trailing twelve-month revenue of $10.04 million, has entered into a ...

Scorpius Holdings, Inc., a pharmaceutical company with a market capitalization of $1.36 million, has entered into a material definitive agreement through the issuance of a non-convertible promissory ...